Article Versions Notes

Gąsior-Perczak D, Kowalik A, Gruszczyński K, Walczyk A, Siołek M, Pałyga I, Trepka S, Mikina E, Trybek T, Kopczyński J, et al. Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma. Cancers. 2021; 13(3):470. https://doi.org/10.3390/cancers13030470

Gąsior-Perczak, Danuta, Artur Kowalik, Krzysztof Gruszczyński, Agnieszka Walczyk, Monika Siołek, Iwona Pałyga, Sławomir Trepka, Estera Mikina, Tomasz Trybek, Janusz Kopczyński, and et al. 2021. "Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma" Cancers 13, no. 3: 470. https://doi.org/10.3390/cancers13030470

Gąsior-Perczak, D., Kowalik, A., Gruszczyński, K., Walczyk, A., Siołek, M., Pałyga, I., Trepka, S., Mikina, E., Trybek, T., Kopczyński, J., Suligowska, A., Ślusarczyk, R., Gonet, A., Jaskulski, J., Orłowski, P., Chrapek, M., Góźdź, S., & Kowalska, A. (2021). Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma. Cancers, 13(3), 470. https://doi.org/10.3390/cancers13030470